Home / Market News / $MCK

$MCK news and market catalysts

The 29 most recent market catalysts affecting $MCK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

29 catalysts 7 high impact 24 bullish 1 bearish Healthcare Distribution
Nov 17, 2026 Corporate Catalyst Bullish Impact 55
Analyst Updates McKesson Price Target
Analyst Glen Santangelo has updated his outlook on McKesson Corporation, raising the price target from $1,000 to $1,235 and maintaining a 'Buy' rating. This action signals a streng…
Nov 16, 2026 Corporate Catalyst Bullish Impact 55
Ontada Announces New AI Capabilities for iKnowMed Customers
Ontada, a subsidiary of McKesson, has introduced new AI capabilities for its iKnowMed platform, which serves oncology providers. This development is significant because it aims to …
Nov 10, 2026 Corporate Catalyst Bullish Impact 55
JPMorgan Adjusts Price Target on McKesson to $1,255 From $1,042
JPMorgan's decision to raise McKesson's price target from $1,042 to $1,255 indicates a more favorable outlook on the company's valuation. This is a positive signal for McKesson, as…
Nov 6, 2026 Corporate Catalyst Neutral Impact 55
Wall Street Analysts Update McKesson Price Targets
This filing indicates that major Wall Street firms like Morgan Stanley and Bank of America Securities have raised their 12-month price targets for McKesson Corporation, while maint…
Nov 6, 2026 Corporate Catalyst Bullish Impact 90
McKesson and Clayton, Dubilier & Rice Secure Financing for Option Care Health Acquisition
McKesson Corporation and Clayton, Dubilier & Rice have initiated the financing process for their acquisition of Option Care Health, securing a $3.1 billion debt package. This devel…
Nov 6, 2026 Corporate Catalyst Bullish Impact 92
McKesson and Clayton, Dubilier & Rice Secure $3.1 Billion Financing for Option Care Health Acquisition
This 8-K filing discloses that McKesson Corporation, in partnership with Clayton, Dubilier & Rice (CD&R), has initiated the process of securing $3.1 billion in debt financing for t…
Nov 5, 2026 Corporate Catalyst Bullish Impact 92
McKesson Reports Fiscal Q2 2027 Results, Raises Guidance, and Announces Strategic Expansion
McKesson reported robust fiscal Q2 2027 results, surpassing revenue and EPS estimates, which led to a significant upward revision of its full-year adjusted EPS guidance. This stron…
Nov 5, 2026 Corporate Catalyst Bullish Impact 65
Evercore ISI Group Raises McKesson Price Target to $1,200
Evercore ISI Group raised its price target for McKesson Corporation (MCK) by 20% to $1,200, while reiterating an 'Outperform' rating. This analyst upgrade signals increased confide…
Nov 5, 2026 Corporate Catalyst Bullish Impact 55
TD Cowen Raises Price Target on McKesson
TD Cowen has raised its price target for McKesson Corporation (MCK) to $1,200, a significant increase from its previous target of $1,006. This adjustment comes after McKesson's rec…
Nov 4, 2026 Corporate Catalyst Bullish Impact 85
McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation announced its financial results for the second quarter of fiscal 2027, which were strong enough to prompt the company to raise its full-year adjusted EPS guida…
Oct 30, 2026 Corporate Catalyst Bullish Impact 65
Morgan Stanley Raises Price Target on McKesson
Morgan Stanley analyst Erin Wright has raised her price target on McKesson (MCK) from $977 to $1,207, while reiterating a bullish rating. This upward revision indicates a more opti…
Oct 26, 2026 Corporate Catalyst Bullish Impact 55
Study Highlights Impact of Ambient AI on Oncology Practice Efficiency
McKesson, through its US Oncology division, co-authored a study demonstrating the significant positive impact of ambient AI on oncology practice efficiency. This matters because it…
Oct 16, 2026 Corporate Catalyst Bullish Impact 55
UBS Maintains Buy on McKesson, Raises Price Target to $1200
UBS analyst Kevin Caliendo maintained a 'Buy' rating on McKesson (MCK) and raised the price target from $1080 to $1200. This action reflects an updated positive outlook from a majo…
Oct 15, 2026 Market Technicals Neutral Impact 55
Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
The filing details Jim Cramer's recent stock picks and pans, offering insights into his current market sentiment. Cramer's endorsements for McKesson and Medtronic, coupled with sup…
Oct 1, 2026 Corporate Catalyst Bullish Impact 75
McKesson shares are trading higher after the company reiterated its FY27 adjusted EPS guidance.
McKesson's reiteration of its FY27 adjusted EPS guidance is a strong corporate catalyst, indicating management's confidence in its long-term financial trajectory. This reduces unce…
Oct 1, 2026 Corporate Catalyst Bullish Impact 55
McKesson Reiterates FY27 Adjusted EPS Outlook Range Of $44.20 To $45
McKesson Corporation (MCK) filed an 8-K to reiterate its previously issued fiscal year 2027 adjusted EPS guidance of $44.20 to $45.00 and its long-term adjusted EPS growth rate of …
Aug 25, 2026 Corporate Catalyst Bullish Impact 90
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
McKesson's acquisition of Precision Medicine Group for $2.25 billion is a major strategic move to bolster its clinical research and commercialization services. This deal allows McK…
Aug 25, 2026 Corporate Catalyst Neutral Impact 75
McKesson To Acquire Precision Medicine Group For ~$2.25
This acquisition is a significant corporate catalyst for McKesson, signaling a strategic focus on expanding its high-growth oncology and specialty care segments. The deal is likely…
Aug 19, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Overweight on McKesson, Raises Price Target to $1000
Barclays analyst Glen Santangelo maintained an 'Overweight' rating on McKesson (MCK) and raised the price target from $925 to $1000. This action signals a positive outlook from a p…
Aug 19, 2026 Corporate Catalyst Neutral Impact 55
RBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845
RBC Capital's initiation of coverage on McKesson (MCK) with a 'Sector Perform' rating and an $845 price target is a routine event in the life of a publicly traded company. While no…
Aug 11, 2026 Corporate Catalyst Bullish Impact 55
Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933
Wells Fargo analyst Stephen Baxter maintained an 'Equal-Weight' rating on McKesson (MCK) but significantly raised the price target from $812 to $933. This action signals a more opt…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1006
TD Cowen analyst Charles Rhyee maintained a 'Buy' rating on McKesson and raised the price target from $989 to $1006. This action signals continued bullish sentiment from a prominen…
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
UBS Maintains Buy on McKesson, Raises Price Target to $1080
UBS analyst Kevin Caliendo maintained a 'Buy' rating on McKesson (MCK) and raised the price target from $1050 to $1080. This action signals continued bullish sentiment from a major…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
McKesson shares are trading lower despite reporting better-than-expected Q2 financial results and raising FY26 adjusted EPS guidance with its midpoint above estimates. The company's FY26 sales guidance midpoint is slightly above estimates, and management noted lower branded pharmaceutical pricing on its conference call.
McKesson's stock decline despite positive financial results highlights investor sensitivity to future revenue and margin pressures, specifically from 'lower branded pharmaceutical …
Aug 6, 2026 Corporate Catalyst Bullish Impact 55
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1000
Evercore ISI Group analyst Elizabeth Anderson maintained an 'Outperform' rating on McKesson (MCK) and raised the price target from $860 to $1000. This action signals a strong vote …
Aug 5, 2026 Corporate Catalyst Bullish Impact 85
McKesson shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 adjusted EPS guidance.
McKesson's positive earnings surprise and raised guidance are a strong bullish signal for the company, indicating effective management and a healthy demand environment for its serv…
Aug 5, 2026 Corporate Catalyst Bullish Impact 90
McKesson Q1 Adj. EPS $9.93 Beats $9.54 Estimate, Sales $105.380B Beat $103.738B Estimate
McKesson announced Q1 adjusted EPS of $9.93, significantly beating the $9.54 consensus estimate, and sales of $105.38 billion, also surpassing the $103.738 billion estimate. This s…
Jul 24, 2026 Corporate Catalyst Bullish Impact 55
Citigroup Maintains Buy on McKesson, Raises Price Target to $1000
Citigroup analyst Daniel Grosslight has maintained a 'Buy' rating on McKesson and raised the price target from $945 to $1000. This action signals increased analyst confidence in Mc…
Jul 22, 2026 Corporate Catalyst Bullish Impact 55
McKesson Raises Quarterly Dividend From $0.82 To $0.94 Per Share
McKesson's Board of Directors declared a 15% increase in its quarterly dividend, raising it from $0.82 to $0.94 per share. This action demonstrates the company's strong financial h…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.